Legal Alerts

AHPA keeps members and the industry informed of recent news and developments that impact the trade through email alerts. Subscribe to news as it happens or a weekly summary of all alerts.

• Lacey Act Phase VII import declaration enforcement begins December 1 - APHIS webinar October 30

• FDA warns Restorative Botanicals for alleged cGMP violations

• July 1 deadline for multistate packaging law registration

• Penn Herb Co recalls Nature’s Wonderland Thyroid Formula due to possible health risk

• USDA APHIS to greatly increase agricultural inspection fees

• USDA APHIS announces Dec 1 Lacey Act import declaration enforcement for essential oils, other plant commodities

• Registration for CA EPR law generally required by July 1

• FDA releases draft guidance on NDIN Master Files

• FDA releases draft revised hazard analysis and risk-based preventive controls guidance

• FDA warns of toxic yellow oleander alleged in multiple tejocote products; recall issued

• FDA warns Lone Star Botanicals for alleged FD&C drug claims, alleged cGMP and labeling violations

• FDA releases final guidance on cosmetic facility registration and product listing

• FDA warns multiple companies for alleged unapproved homeopathic eye drops

• Consent decrees entered against Utah dietary supplement manufacturer and distributor

• FDA warns Innomark for alleged cGMP and label violations

• FDA delays MoCRA facility registration and product listing enforcement to next July

• New York passes weight loss/muscle building supplement age restriction law

• FDA warns Day Light Nutrition for alleged FD&C drug claims

• FDA warns Shot of Joy LLC for alleged FD&C drug claims

• California food ingredient ban passes legislature

• New EU pesticide maximum residue limits to take effect September 14

• Multiple nuez de la India products recalled for containing toxic yellow oleander

• FDA warns Cosmax NBT USA for alleged cGMP and labeling violations

• New EU pesticide maximum residue limits to take effect September 14

• FDA warns Hekma Center, LLC for alleged FD&C drug claims

• NPA issues citizen petition to FDA regarding dietary supplement labeling of mushrooms and mycelia

• FDA warns Five Leaf Pet Botanicals for alleged FD&C animal drug claims

• FDA warns Eden’s Answers for alleged cGMP and labeling violations

• Rejuvica LLC agrees to permanent injunction regarding FTC unsubstantiated health claim and false endorsement charges

• FDA warns Sunshine Trading Company for alleged FD&C drug claims

• FDA warns Brand Packaging Group for alleged cGMP violations

• BBB direct selling council refers Wayal Health to FTC for alleged unsubstantiated health claims

• TruVision Health recalls products due to possible health risk

• U.S. Fish & Wildlife Service alerts U.S. importers and exporters of the importance of compliance with CITES requirements

• FDA issues draft guidance on labeling of plant-based milk alternatives

• FDA issues betel nut import alert

• USDA APHIS announces planned Lacey Act essential oil coverage

• Lipari Foods recalls ground cumin due to potential contamination

• FDA warns Herbal Vitality for alleged FD&C drug claims, cGMP and labeling violations

• FDA warns Quality Supplement Manufacturing for alleged cGMP violations

• FDA warns Adept Life Science for alleged cGMP violations

• FTC releases new health products compliance guidance

• FDA releases final homeopathic drug guidance (FDA)

• FDA warns Saffron USA LLC for alleged FD&C drug claims (FDA)

• FDA warns Rosebud's Ranch and Garden, LLC for alleged FD&C drug claims (FDA)

• FDA warns The Truth Company, LLC for alleged FD&C drug claims (FDA)

• FDA warns seven companies for alleged FD&C cardio drug claims (FDA)

• FDA warns NatureLab Corp for alleged cGMP violations (FDA)

• District court enjoins Arizona company from distributing adulterated/misbranded dietary supplements (DoJ)

• Fenugreek seed powder recall updated to Class I (FDA)

• FDA and FTC send letters to Lakpura LLC for alleged FD&C COVID-19 drug claims (FDA)

• The Chai Box recalls bottled products due to potential contamination (FDA)

• FDA warns Muscle Sports Products, LLC for alleged FD&C drug claims (FDA)

• FDA warns Nutritional Laboratories Int’l for alleged cGMP violations (FDA)

• USDA APHIS to replace import database and manuals with new ACIR database (USDA)

• FDA warns The Elderberry Fairy & Co., LLC for alleged FD&C drug claims (FDA)

• APHIS PPQ to permanently accept electronic phytosanitary certificate copies October 1, 2022 (USDA)

• FDA releases finalized NAC enforcement discretion guidance (FDA)

• FDA warns Muscle Feast, LLC for alleged cGMP violations (FDA)

• South Carolina man receives one-year prison sentence for sale of illegal drugs labeled as dietary supplements (DOJ)

• BBB direct selling council recommends Root Wellness discontinue claims (BBB)

• FDA warns New Sun Inc. for alleged FD&C drug claims (FDA)

• FDA supplements proposed ag water rule with new compliance dates (FDA)

• FDA/FTC warn MONQ, LLC for alleged FD&C drug claims (FDA/FTC)

• FDA/FTC warn four kratom companies for alleged FD&C drug claims (FDA/FTC)

• FDA warns DLG Naturals, Inc. for alleged FD&C drug claims

• FDA warns Santhigram Kerala Ayurvedic Co. of U.S., Inc. for alleged FD&C drug claims (FDA)

• FDA warns Ayuryoga, Inc. for alleged FD&C drug claims (FDA)

• AHPA publishes comparison document for heavy metals standards

• FDA warns 11 companies for alleged adulteration (FDA)

• FDA retracts warning letter to Glanbia, Inc. (FDA)

• FDA warns MCACO, Ltd for alleged cGMP violations (FDA)

• FDA warns 5 companies for alleged CBD and Delta-8 FD&C drug claims

April 2022

• FTC proposes full ban on dietary supplement sales by Health Research Laboratories and Whole Body Supplements (FTC)

• Reckitt recalls 3 million Airborne brand gummy bottles due to decompression hazard (CPSC)

March 2022

• FDA warns Princess Lifestyles for alleged FD&C drug claims, CGMP, other violations (FDA)

February 20222

• AHPA article provides context for reduced FDA inspections of dietary supplement facilities

• FDA resumes domestic surveillance inspections (RAPS)

• FDA releases industry guidance on chlorpyrifos residues following tolerance revocation (FDA)

• FDA releases informational video on FASTER Act (FDA)

January 2022

• Blackstone Labs founder receives multiyear prison sentence for conspiracy involving illegal products labeled as supplements (DoJ)

• FDA to hold public meetings on proposed agricultural water rule revision (FDA)

• FDA Announces Qualified Health Claims for Magnesium and Reduced Risk of High Blood Pressure (FDA)

December 2021

• FDA warns Synaptent, LLC for alleged FD&C drug claims (FDA)

November 2021

• Mountain Meadow Herbs recalls certain Candida Flush bottles due to explosion risk

• Blackstone Labs and Executives plead guilty to conspiracy involving illegal products labeled as supplements (DoJ)

October 2021

• EPA announces trifloxystrobin tolerance petition for new Spice Crop Group (EPA)

• FTC closes NARB referred case regarding Avadim Health, Inc (FTC)

• FDA warns ICA Health, LLC/Future Formulations, LLC for alleged FD&C drug claims (FDA)

September 2021

• FDA warns Fibromyalgia Treatment Group - FTG, LLC for alleged FD&C drug claims (FDA)

• FDA warns McDaniel Water, LLC for alleged FD&C drug claims (FDA)

• FDA warns American Metabolix for alleged FD&C drug claims, product adulteration (FDA)

• EPA announces first IR-4 tolerance petition for new Spice Crop Group (EPA)

• HSA/FSA/RSA supplement legislation introduced in U.S. House (Congress.gov)

• FDA warns Brilliant Enterprises LLC for alleged FD&C drug claims (FDA)

• FDA and FTC warn 10 companies for alleged diabetes FD&C drug claims (FDA)

• Florida man pleads guilty to conspiracy involving illegal products labeled as supplements (DoJ)

August 2021

• Louisiana Constable pleads guilty in federal court on misbranded drug charge (DoJ)

• Recent California Proposition 65 activity includes notices for naturally-occurring chemicals

• EPA to revoke all tolerances, registrations for pesticide Chlorpyrifos

• EPA announces petition for new pesticide tolerance in new herb and spice crop groups (EPA)

• Multiple substances planned for sunset removal from NOSB National List (USDA)

• FDA warns 3RD Day Nutraceuticals, LLC for alleged FD&C drug claims

July 2021

• Senators request multimillion dollar budget increase for ODSP (US Senate)

• USDA APHIS announces Oct 1 date for Lacey Act Phase VI enforcement (Federal Register)

June 2021

• FDA warns JLM Nutritionals, Inc. for alleged FD&C drug claims (FDA)

• FDA warns Fresh Nutrition Inc for alleged FD&C drug and animal drug claims (FDA)

• Bea Lydecker’s Naturals recalls certain Living Free supplement products due to undeclared soy lecithin (FDA)

• FDA warns Red's Kitchen Sink at Bourbon Street Ice for alleged FD&C drug claims (FDA)

May 2021

• FDA warns Immune & Genetics Protocols, LLC for alleged FD&C drug claims

• FDA announces notice for preliminary research on symbols to convey nutrient claim “healthy” to consumers

• FDA warns Unived Inc for alleged FD&C drug claims

• USDA adds stevia to Lacey Act exempted common cultivar list

April 2021

• FDA warns Orphic Nutrition for alleged FD&C drug claims

• Congress adds sesame to list of major food allergen (Kleinfeld, Kaplan, & Becker)

• AHPA engages California legislature on Prop 65 and weight supplement bills

• FDA warns Maison Terre for alleged FD&C CGMP violations and drug claims

March 2021

• FDA warns two companies for alleged sale of CBD OTC topical products

• New York supplement manufacturer receives permanent injunction for CGMP violations

February 2021

• FDA warns ten companies for alleged FD&C mental health drug claims

• FDA warns Prairie Dawn Herbs for alleged FD&C drug claims

• FDA warns Entia Biosciences, Inc for alleged FD&C drug claims

• FDA warns American Global Health Group, LLC for alleged FD&C drug claims

January 2021

• FDA warns Sage Moon Apothecary, LLC for alleged FD&C drug claims

• FDA warns Bodyhealth.com, LLC for alleged FD&C drug claims

• FDA warns Smarter Nutrition, Inc. for alleged FD&C drug claims

• FDA warns Bonagens for alleged FD&C drug claims

• FDA warns Speedwinds Nutrition, Inc. for alleged FD&C drug claims

• FDA warns Valentus, Inc. for alleged FD&C drug claims

• FDA warns Natures Boost LLC for alleged FD&C drug claims

• AHPA applauds FDA public warning on alleged misbranded drugs marketed online

• FDA warns Reddy Naturals for alleged FD&C drug claims

December 2020

• Federal guilty plea by SARMS marketer for unapproved new drug distribution

• FDA warns Quten Research Institute, LLC for alleged FD&C violations

• Fusion Health and Vitality LLC issues voluntary nationwide recall

November 2020

• FDA warns Half Hill Farm Inc. for alleged FD&C violations

• FDA Warns three companies for alleged drug claims

October 2020

• Customs and Border Protection asserts certain Chinese stevia extracts produced with prison labor, bars import (Federal Register)

• FDA & FTC warn Tonic Therapeutic Herb Shop & Elixir Bar for alleged COVID-19 claims

September 2020

• FDA Provides Additional Flexibility Regarding Nutrition and Supplement Facts Labels

• FDA & FTC warn Pharmacy Plus, Inc. for alleged COVID-19 claims

• FDA rejects oleandrin as a dietary supplement ingredient (CNN)

• FDA and FTC warn two more companies for alleged COVID-19 claims

• FDA warns Hampshire Labs, Inc. for alleged prostate and lung claims

• FDA warns two companies for claims related to opioid addiction

• FDA warns Revival Products for alleged cGMP violations

August 2020

• Maison Terre Issues Voluntary Nationwide Recall of Organic Goldenseal Root Powder Due to Microbial Contamination (FDA)

• FDA warns Custom Nutraceuticals for alleged cGMP violations (FDA)

• FDA and FTC warn Living Senior for alleged COVID-19 claims for CBD products

• Resources for food producers in areas affected by storms Laura and Marco (FDA)

• FDA and FTC warn SilveryGuy for alleged COVID-19 claims made for Amazon Associates product

• FDA and FTC warn Canadian Chaga for alleged COVID-19 claims (FDA & FTC)

• FDA warns New Genesis Health for alleged cGMP violations (FDA)

July 2020

• FDA Warns Seven Companies Allegedly Illegally Selling Hangover Remedies (FDA)

• FDA announces qualified health claim for certain cranberry products and urinary tract infections (FDA)

• USDA AMS final guidance on bioengineered food disclosure (Federal Register)

• FDA looks to resume domestic on-site inspections during the week of July 20 (FDA)

• APHIS will continue to accept electronic phytosanitary certificates and forms through Sept. 30 (USDA)

• FDA issues Final Rule on safe use of vitamin D2 mushroom powder as a nutrient supplement (Federal Register)

• FDA and FTC warn three more companies for alleged COVID-19 claims (FDA & FTC)

• FDA warns Washington Homeopathic Products for alleged cGMP violations (FDA)

• FDA and FTC warn seven more companies for alleged COVID-19 claims (FDA)

• FDA warns Only Natural, Inc. for alleged drug claims and labeling violations (FDA)

• FDA and FTC warn three more companies for alleged COVID-19 claims (FDA)

June 2020

• FDA warns BHP Holdings for allegedly failing to review all product complaints (FDA)

• FDA and FTC warn six more companies for alleged COVID-19 claims (FDA)

• FDA and FTC warn two more companies for alleged COVID-19 related claims (FDA)

• FDA warns Morningstar Minerals for alleged cGMP violations and drug claims (FDA)

• FDA warns NutraCap Labs for products allegedly containing DMHA (FDA)

• FDA and FTC warn three more companies for alleged COVID-19-related claims (FDA)

• FDA and FTC warn 7 more companies for alleged COVID-19 claims (FDA)

• Federal judge enters order of permanent injunction against company for allegedly distributing unapproved drugs (FDA)

May 2020

• FDA warns Humaworm for alleged labeling and marketing claims violations

• FTC refunding more than $8.5 million to consumers defrauded by misleading supplement claims

• FDA and FTC warn more companies for alleged unapproved and misbranded products related to COVID-19

• FDA warns 15 more companies for claims related to COVID-19

• FDA warns Global Vitality for alleged drug claims and cGMP and labeling violations (FDA)

• FDA warns four more companies for promoting drugs, homeopathic products and supplements for COVID-19

• FDA warns Hawaii Pharm LLC for alleged violations of FDA dietary supplement regulations (FDA)

• FDA warns JusByJulie.Com LLC for alleged drug claims (FDA)

April 2020

• FDA warns Earth Angel Oils for products allegedly promoted for COVID-19 (FDA)

• FDA warns Nova Botanix LTD DBA CanaBD for CBD products allegedly promoted for COVID-19 (FDA)

• FDA warns KetoKerri LLC for alleged drug claims on Amazon storefront, website, Facebook page and product literature (FDA)

• FDA warns Herbs of Kedem for products allegedly promoted for COVID-19 (FDA)

• FTC announces 10 warning letters issued over Coronavirus related products (FTC)

• FDA and FTC warn four companies for alleged COVID-19 claims

• FDA and FTC warn five more companies for alleged COVID-19 claims

• FDA warns 360 Bullet Inc. over unapproved new drugs and adulterated supplements (FDA)

• FDA warns Carahealth for alleged COVID-19 claims (FDA)

• USDA extends expiration dates for some good agricultural practices, domestic origin verification, plant systems audit program ciertifications (USDA)

March 2020

• FDA guidance on Adverse Event Reporting During a pandemic (FDA)

• FDA and FTC warn seven companies selling fraudulent products that claim to treat or prevent COVID-19

February 2020

• FDA warns R-Garden LLC for alleged therapeutic claims and cGMP violations (FDA)

• FDA warns Evig LLC for alleged drug claims on website, YouTube channel and product labeling (FDA)

• FDA warns Wave Miami for drug-spiked products masquerading as supplements (FDA Warning Letter)

January 2020

• FDA grants citizen petition on glucomannan as a dietary fiber (FDA)

• Sen. Schumer urges HHS probe into alleged adulterated dietary supplements (Sen. Schumer Press Release)

• Federal district court orders company to stop distributing alleged adulterated and misbranded dietary supplements (US DOJ)

December 2019

• FDA warns Prolifix Nutrition for alleged cGMP violations (FDA)

November 2019

• FDA warns 15 companies for allegedly selling CBD products that violate the FD&C Act (FDA)

• FDA warns Revital U International for products with DMHA (FDA warning letter)

• FDA withdraws compliance policy guide on homeopathic drug products and issues revised draft guidance (KKB)

October 2019

• FDA, FTC warn company marketing unapproved cannabidiol products with unsubstantiated claims

• FDA warns Paisley Farms for alleged drug claims and cGMP, labeling violations(FDA warning letter)

• FDA warns Ibitta Enterprises for alleged cGMP and labeling violations

• FDA warns Herbal Healer Academy for alleged therapeutic claims (FDA Warning Letter)

• FDA warns Alternative Laboratories for products labeled to contain DMHA and CBD (Warning Letter)

September 2019

• FDA warns contract manufacturer Nutra Solutions for alleged cGMP violations (Warning Letter)

• FDA warns Absonutrix, LLC for alleged cGMP and labeling violations (FDA)

• FDA warns Sportron International for alleged cGMP violations related to contract manufacturing (FDA)

• Consent decree entered against drug, dietary supplement and device distributors (FDA)

• FDA modifies processes for NDI and structure/function claim notification submissions (FDA)

August 2019

• FDA warns H & A Walters Fulfillment Center for alleged cGMP violations (FDA)

• FDA warns Let's Talk Health for alleged cGMP violations and drug claims

• First warning letter for failure to develop FSVP (FDA Law Blog)

• FDA warns Premium Production LLC for alleged cGMP violations (FDA Warning Letter)

• FDA warns Perfect Choice Trading, Inc. and Nutricos Ceuticals, Inc. (FDA Warning Letter)

July 2019

• FDA warns Ceba-Tek for alleged cGMP violations (FDA Warning Letter)

• Guidance on using 'natural' claims issued by Australia's Therapeutic Goods Administration (TGA)

• FDA warns KratomNC for kratom products marketed to treat or cure opioid addiction (FDA)

• FDA warning letter to HealthTech International Inc. alleges cGMP and labeling violations (Warning Letter)

June 2019

• FDA warns Cali Botanicals for kratom products marketed to treat or cure opioid addiction (FDA)

• FDA warns SomaLabs for inadequate responses to alleged cGMP violations (FDA)

• FDA warns PRL Inc for alleged cGMP violations and therapeutic claims (Warning Letter)

• FDA Updates FSMA FAQ to Include Questions and Answers on Produce Safety (FDA)

• FDA warns ActiveHerb Technology claims on traditional uses that FDA interprets as drug claims (FDA Warning Letter)

• Forest service announces 2019 ginseng lottery (The Mountaineer)

• FDA statement on warning for women of childbearing age about possible safety risks of dietary supplements containing vinpocetine

May 2019

• Complaint Filed Against Company to Stop Distribution of Adulterated Dietary Supplements (DOJ)

• Man receives two-year prison sentence for importing and selling misbranded kratom (US DOJ)

• FDA warns manufacturers of products labeled as homeopathic (FDA)

April 2019

• FDA Launches New Dietary Supplement Ingredient Advisory List

• Geniux Dietary Supplement Sellers Barred from Unsupported Cognitive Improvement Claims (FTC)

• ALERT: Medical Cannabis Research Act Stirs DEA Marijuana Registration Pot (FDA Law Blog)

• FDA public hearing on cannabis product safety, manufacturing, quality, marketing, labeling, and sales (Federal Register)

• FDA warns three CBD companies for online marketing claims (FDA Warning Letter)

• FDA warns four homeopathic firms alleging violations of manufacturing quality standards (FDA Warning Letter)

March 2019

• FDA warns IMedDo for alleged website claims that establish products as drugs (FDA Warning Letter)

• Additional Certification Bodies Accredited Under FDA’s Accredited Third-Party Certification Program (FDA)

• FDA to Hold Public Meeting to Discuss Responsible Innovation in Dietary Supplements (FDA)

• FDA warns Nutra Pharma for alleged drug claims used to market products labeled as homeopathics (FDA Warning Letter)

• FDA warns Hanna's Herb Shop for alleged drug claims (FDA Warning Letter)

• Six people, two companies charged in scheme to sell illegal products fraudulently represented dietary supplements (DOJ)

• FDA warns Phi Sciences for alleged cGMP violations and drug claims (FDA Warning Letter)

• FDA Commissioner Scott Gottlieb to step down (New Hope)

• FDA warns Green Water, LLC for alleged cGMP violations and drug claims (FDA)

February 2019

• FDA takes action against 17 companies for illegally selling products claiming to treat Alzheimer’s disease (FDA)

January 2019

• Circuit court affirms summary judgment in favor of dietary supplement manufacturer in deceptive labeling class action (Dentons)

• Senators ask FDA to update rules on certain hemp products (Associated Press) 01/15/2019

• USDA’s final rule for GMO labeling ignores recommendations of consumers and AHPA 01/08/2019

• Colorado Department of Agriculture announces certified hemp seed varieties (High Plains/Midwest AG J) 01/08/2019

• Surgeon General calls for marijuana reclassification (Forbes) 01/07/2019

• State proposes regulations on hemp crop (Illinois News Network) 01/06/2019

December 2018

• Nutritional supplements access preserved in Arizona 12/17/2018

• FDA warns DynaPro International for alleged cGMP violations and drug claims (FDA) 12/11/2018

• DynaPro International for alleged cGMP violations and drug claims (FDA) 12/11/2018

November 2018

• FDA warns marketers of products labeled as dietary supplements that contain tianeptine for making unproven claims (FDA) 11/21/2018

• FDA warns consumers to avoid Rhino male enhancement products found at retailers because of undeclared and potentially dangerous drug ingredients (FDA) 11/27/2018

• FDA Warns Delano Company/LifeLink for failing to register manufacturing facility (FDA) 11/27/2018

October 2018

• FDA warns Duy Drugs for products allegedly spiked with drugs (FDA) 10/02.2018

• FDA launches global operation to crack down on websites selling illegal, potentially dangerous drugs; including opioids (FDA) 10/23/2018

• Sirob Imports, Inc. Issues Recall Due to Elevated Lead in Spices (FDA) 10/29/2018

• FDA warns Original Living Coconut for marketing food products with drug claims (FDA) 10/31/2018

September 2018

• FDA commissioner issues statement on companies marketing kratom with unproven medical claims (FDA) 9/11/2018

• FDA webinar to help food importers understand VQIP (FDA) 9/13/2018

• FDA issues resource materials to determine if businesses are qualified facilities under FSMA preventive controls rule (FDA) 9/14/2018

• FDA warns Best Nutrition Products for alleged cGMP and labeling violations (FDA) 9/18/2018

• FDA warns Celletech for claims that establish products as drugs (FDA) 9/18/2018

August 2018

• FDA warns www.poppyseedwash.com for therapeutic claims (FDA) 8/14/2018 

• FDA warns Signature Formulations for marketing CBD products as dietary supplements (FDA) 8/15/2018

• FDA warns Healthy Healing-Crystal Star for drug claims and alleged cGMP violations (FDA) 8/21/2018

• FDA expresses support for exempting coffee from CA Prop 65 cancer warnings (FDA) 8/30/2018

July 2018

• FDA warns GC Natural for alleged cGMP and labeling violations (FDA) 7/31/2018

• European Court rules that gene editing is genetic engineering (BBC News)

• FDA warns Aegle Nutrition for inadequate responses to alleged cGMP and labeling violations (FDA) 7/17/2018

• Allergy Alert on Undeclared Allergens in Prescript-Assist Dietary Supplement (FDA) 7/2/2018

July 2018

• FDA warns GC Natural for alleged cGMP and labeling violations (FDA) 7/31/2018

• European Court rules that gene editing is genetic engineering (BBC News)

• FDA warns Aegle Nutrition for inadequate responses to alleged cGMP and labeling violations (FDA) 7/17/2018

• Allergy Alert on Undeclared Allergens in Prescript-Assist Dietary Supplement (FDA) 7/2/2018

June 2018

• Proposed OEHHA regulation clarifies that cancer warnings are not required for coffee under Proposition 65 (OEHHA) 6/20/2018

• FDA warns Health Management Group for alleged cGMP and labeling violations (FDA) 6/20/2018

• FDA releases draft guidance for FSMA intentional adulteration rule (FDA) 6/19/2018

• FDA issues guidance, science review, and citizen petition responses on dietary fiber (FDA) 6/18/2018

• FDA warns Dual Health Body and Mind for selling pure caffeine powder (FDA) 6/12/2018

• FDA warns Silver Armor, Inc. for therapeutic claims and alleged cGMP violations (FDA)  6/5/2018

• FDA warns companies to stop selling dangerous and illegal pure and highly concentrated caffeine products (FDA) 6/5/2018

• AHPA recommends oshá harvest permitting in GMUG National Forests 6/5/2018

May 2018

• FDA warns Performance Nutrition Formulators for Arimistane product and online therapeutic claims (FDA) 5/29/2018

• FDA warns Yoder's Good Health Products for adding Goldenseal and Black Cohosh to conventional food products (FDA) 5/29/2018

• Ethanol Extraction Recalls Alcohol Product Because of Possible Health Risk (FDA)  5/23/2018

• FDA warns companies selling unapproved kratom products marketed for opioid cessation, pain treatment and other medical uses (FDA) 5/22/2018

• FDA commissioner issues statement on the harmful effects of sun exposure and warning letters for firms making disease claims (FDA) 5/22/2018

• AHPA represents member interests at USP Dietary Supplement Stakeholder Forum 5/17/2018

• FDA warns Baker's Best Health Products Inc. for website claims and misbranded products (FDA) 5/17/2018

• FDA warns Chi's Enterprise Inc. for multiple alleged cGMP violations (FDA) 5/17/2018

• FDA to extend compliance dates for Nutrition Facts Label and Serving Size Final Rules (Federal Register) 5/3/2018

• AHPA endorses the Hemp Farming Act of 2018 5/3/2018

April 2018

• AHPA President Michael McGuffin urges companies selling kratom to comply with all applicable laws and regulations  4/25/2018

• AHPA recommends CBD not be scheduled under any international drug control convention 4/24/2018

• Rate of NDI notifications reported by FDA unexpectedly drops 4/24/2018

• Chuck Schumer To Introduce Bill To Decriminalize Marijuana (NPR) 4/20/2018

• FDA warns Amerigo Labs for alleged online therapeutic claims and labeling violations (FDA) 4/17/2018

• AHPA supports FDA guidance making pure or highly concentrated caffeine dietary supplements unlawful 4/13/2018

• FDA warns Vital Hierbas Naturales Corporation for alleged drug claims and labeling violations (FDA) 4/10/2018

• FDA warns South Texas Botanicals for alleged disease claims and cGMP and labeling violations (FDA)  4/10/2018

• FDA warns Ozark Country Herbs for alleged disease claims and cGMP and labeling violations (FDA)  4/10/2018

• FDA warns Secret Garden of Health & Healing for alleged disease claims and cGMP and labeling violations (FDA)  4/10/2018

• FDA orders mandatory recall for kratom products due to risk of salmonella (FDA)  4/4/2018

• Chinese Citizen Pleads Guilty to Mail Fraud and Smuggling Related to Dietary Supplement Scheme (DOJ)  4/4/2018

• Calif. Judge Rules Coffee Must Come With A Cancer Warning, But Should It? (NPR) 4/3/2018

• Permanent injunction entered against company for selling products with undisclosed active pharmaceutical ingredients (DOJ)  4/2/2018

March 2018

• District Court Orders Long Island Company to Stop Distributing Adulterated and Misbranded Dietary Supplements (DOJ) 3/30/2018

• FDA warns Biotek alleged contract manufacturing cGMP violations (FDA) 3/27/2018

• Trump Signs Omnibus Spending Bill With Boost in FDA Funding (Regulatory Focus)  3/23/2018

• FDA using innovative methods to prevent illegal products with hidden drug ingredients from entering the US (FDA)  3/22/2018

• FDA issues draft guidance to help businesses determine the number of employees for the "Small Business" definition in two FSMA regulations (FDA)  3/19/2018

•  3/14/2018

• FDA warns Minnesota Emu for drug claims and failing to register facility (FDA) 3/14/2018

• FDA warns Carol Bond Health Foods for inadequate responses to alleged cGMP violations (FDA 3/14/2018

• Company recalls kratom products due to potential Salmonella contamination (FDA) 3/13/2018

• FDA warns Nutritional Engineering for alleged cGMP violations and inadequate responses to inspector observations (FDA 3/13/2018

• FDA releases Guidance on fiber and several other key issues (CFSAN)  3/1/2018

February 2018

• FDA warns Terra Biological for misbranded medical food marketed with online drug claims 2/27/2018

• FDA oversees destruction and recall of kratom products; and reiterates its concerns on risks associated with this opioid (FDA) 2/23/2018

• FDA investigates multistate Salmonella outbreak linked to kratom products (FDA) 2/21/2018

• Leading scientists question FDA's kratom findings 2/14/2018

• FDA warns Young Health Products for online drug claims (FDA) 2/13/2018

• FDA warns Long Life Unlimited for disease claims in online testimonials (FDA) 2/13/2018

• FDA warns Reishi D. International for alleged cGMP and labeling violations (FDA) 2/13/2018

• FDA warns Long Life Unlimited for disease claims in online testimonials (FDA) 2/6/2018

• AHPA encourages CFSAN to improve regulations for herbal products 2/5/2018

January 2018 

• FDA warns Young Health Products for online drug claims (FDA)  1/31/2018

• FDA issues guidance to help importers and food producers meet FSMA requirements (FDA)  - 1/24/2018

• FDA warns USA Labs for online drug claims (FDA) - 1/23/2018

• FDA warns Coenzyme-A Technologies for drug claims (FDA) - 1/23/2018

• FDA warns Optimum Bioenergy International for labeling violations and inadequate responses to alleged cGMP violations (FDA) - 1/23/2018

• FDA warns Innovita for drug claims and inadequate responses to alleged cGMP violations (FDA) - 1/11/2018

• FDA warns Dynamic Technical Formulations for products containing selective androgen receptor modulators (SARMs) (FDA) - 1/2/2018 

• FDA warns BrainAlert for referencing scientific publications that provide evidence the product is intended to be used as a drug - 1/2/2018

December 2017

• FDA warns for Madison One Acme Inc. dba Solstice Medicine Company drug claims and labeling violations (FDA) - 12/20/2017

• FDA warns GnuPharma Corp. for drug claims, labeling violations and alleged cGMP violations (FDA) - 12/20/2017 

• FDA warns Professional Botanicals for alleged cGMP and labeling violations and drug claims (FDA) - 12/19/2017

• FDA warns Grandma's Herbs for online drug claims (FDA) - 12/19/2017  

• FDA warns Arco Globus Trading for promoting two products as alternatives to street drugs (FDA) - 12/12/2017

• FDA warns Wellness Resources for online drug claims (FDA) - 12/5/2017

November 2017

• FDA Mannatech Incorporated for drug claims, labeling violations and alleged cGMP violations (FDA) - 11/22/2017 

• FDA warns Vita Pure for inadequate responses to alleged cGMP violations (FDA) - 11/22/2017 

• FDA issues public health advisory on the risks of kratom use - 11/22/2017

• FDA Releases Small Entity Compliance Guide for FSMA Sanitary Transportation Rule (FDA) - 11/21/2017

• FDA warns Hello Life, Inc for products with nutrient levels that don't equal amount listed on label (FDA) - 11/15/2017

• FDA warns Biomin Industries for drug claims and alleged cGMP and labeling violations (FDA) - 11/7/2017

• FDA warns three companies for products containing selective androgen receptor modulators (FDA) - 11/2/2017
  FDA warns companies marketing CBD products that claim to treat or cure cancer (FDA) - 11/2/2017 

October 2017

• FDA warns Nexagen for alleged cGMP violations (FDA) - 10/31/2017

• Four Chinese Companies indicted in scheme to sell mislabeled dietary supplements (DOJ) - 10/26/2017

• Enforcement action filed against company and owner to prevent distribution of adulterated and misbranded products (DOJ) - 10/24/2017

• FDA warns Total Body Nutrition for DMAA in several products (FDA) - 10/18/2017

• Supplement maker prohibited from manufacturing products due to alleged cGMP violations (FDA) - 10/16/2017

• FDA and USDA seek input on impacts of agricultural biotechnology (FDA) - 10/12/2017

August 2017

• Three Dietary Supplement Marketers Settle FTC, Maine AG Charges (FTC) - 8/31/2017

• FDA warns Total Nutrition for alleged cGMP violations and drug claims (FDA) - 8/29/2017

September 2017

• Young Living pleads guilty to misdemeanor charges related to illegal trafficking of rosewood and spikenard oil (DOJ) -  9/19/2017

• FDA warns Lopez Gonzalez Santana Corporation for alleged cGMP violations and insufficient information on proposed corrective actions (FDA) - 9/19/2017 

• FDA warns Lopez Gonzalez Santana Corporation for alleged cGMP violations and insufficient information on proposed corrective actions (FDA) - 9/19/2017

• FDA warns MusclMasster, LLC for products with ephedra, drug claims and alleged cGMP violations (FDA) -  9/20/2017

• FDA warns Vicare International for inadequate responses to alleged cGMP violations (FDA) - 9/27/2017

• FDA warns Mega Pro International for therapeutic claims, labeling violations and alleged cGMP violations (FDA) - 9/27/2017

• FDA proposes to extend compliance dates for nutrition facts label final rule (FDA) - 9/29/2017

July 2017

• California Publishes Q&A on New Prop 65 Warning Requirements (OEHHA) - 7/12/2017

• FDA warns New Capstone for drug claims in testimonials and on website (FDA) - 7/11/2017

June 2017

• FDA warns Nature's Vision for alleged cGMP and labeling violations (FDA) - 6/27/2017

• FDA warns Xcel Sports Nutrition for Acacia rigidula products and alleged cGMP violations (FDA) - 6/27/2017

• FDA delaying overhaul of nutrition labels (The Hill) - 6/15/2017 

• FDA warns Bio TE Medical for alleged cGMP and labeling violations (FDA) - 6/7/2017

• FDA warns Life Rising Corporation for alleged cGMP violations and drug claims (FDA) - 6/6/2017

• FDA warns Herbal Doctor Remedies for drug claims (FDA) - 6/6/2017